Product Description: PRL3-CNNM4 PPI IN 1 (Compound C28d52) is an inhibitor of the PRL3-CNNM4 interaction and also inhibits PRL-mediated suppression of CNNM. PRL3-CNNM4 PPI IN 1 is capable of penetrating epithelial cell layers, exhibits metabolic stability, possesses favorable pharmacokinetic and pharmacodynamic properties, and holds potential for drug development based on this compound[1].
Applications: Cancer-programmed cell death
Formula: C8H8O2S
References: [1]Funato Y, et al. Development of a high-throughput screening system targeting the protein-protein interactions between PRL and CNNM[J]. Scientific Reports, 2024, 14(1): 25432.
CAS Number: 40133-06-0
Molecular Weight: 168.21
Compound Purity: 99.33
Research Area: Cancer
Target: Phosphatase